98 related articles for article (PubMed ID: 38142978)
1. Smokers and risk of hospital death by COVID calculated with SAVANA's natural language processing in the Castilla-La Mancha area.
Godoy R; Benavent Núñez M; Cruz J; López Yepes G; Parralejo Jiménez A; Callejas FJ; Izquierdo JL
Rev Clin Esp (Barc); 2024 Jan; 224(1):34-42. PubMed ID: 38142978
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing.
Izquierdo JL; Ancochea J; ; Soriano JB
J Med Internet Res; 2020 Oct; 22(10):e21801. PubMed ID: 33090964
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Gender Differences in the Diagnosis and Management of Coronavirus Disease 2019 Patients: An Analysis of Electronic Health Records Using Natural Language Processing and Machine Learning.
Ancochea J; Izquierdo JL; Soriano JB
J Womens Health (Larchmt); 2021 Mar; 30(3):393-404. PubMed ID: 33416429
[No Abstract] [Full Text] [Related]
4. Smoking and risk of COVID-19 hospitalization.
Puebla Neira D; Watts A; Seashore J; Polychronopoulou E; Kuo YF; Sharma G
Respir Med; 2021 Jun; 182():106414. PubMed ID: 33915414
[TBL] [Abstract][Full Text] [Related]
5. Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study.
Piasecki TM; Smith SS; Baker TB; Slutske WS; Adsit RT; Bolt DM; Conner KL; Bernstein SL; Eng OD; Lazuk D; Gonzalez A; Jorenby DE; D'Angelo H; Kirsch JA; Williams BS; Nolan MB; Hayes-Birchler T; Kent S; Kim H; Lubanski S; Yu M; Suk Y; Cai Y; Kashyap N; Mathew JP; McMahan G; Rolland B; Tindle HA; Warren GW; An LC; Boyd AD; Brunzell DH; Carrillo V; Chen LS; Davis JM; Deshmukh VG; Dilip D; Ellerbeck EF; Goldstein AO; Iturrate E; Jose T; Khanna N; King A; Klass E; Mermelstein RJ; Tong E; Tsoh JY; Wilson KM; Theobald WE; Fiore MC
Nicotine Tob Res; 2023 May; 25(6):1184-1193. PubMed ID: 36069915
[TBL] [Abstract][Full Text] [Related]
6. Real-life burden of hospitalisations due to COPD exacerbations in Spain.
Izquierdo JL; Rodríguez JM; Almonacid C; Benavent M; Arroyo-Espliguero R; Agustí A
ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 35983537
[TBL] [Abstract][Full Text] [Related]
7. [Mortality attributable to tobacco consumption in the years 1987 and 1997 in Castilla la Mancha, Spain].
Criado-Alvarez JJ; Morant Ginestar C; de Lucas Veguillas A
Rev Esp Salud Publica; 2002; 76(1):27-36. PubMed ID: 11905397
[TBL] [Abstract][Full Text] [Related]
8. Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study.
Paleiron N; Mayet A; Marbac V; Perisse A; Barazzutti H; Brocq FX; Janvier F; Dautzenberg B; Bylicki O
Nicotine Tob Res; 2021 Aug; 23(8):1398-1404. PubMed ID: 33420786
[TBL] [Abstract][Full Text] [Related]
9. Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System.
Malden DE; Tartof SY; Ackerson BK; Hong V; Skarbinski J; Yau V; Qian L; Fischer H; Shaw SF; Caparosa S; Xie F
JMIR Public Health Surveill; 2022 Dec; 8(12):e41529. PubMed ID: 36446133
[TBL] [Abstract][Full Text] [Related]
10. Clinical Profile of Patients with Idiopathic Pulmonary Fibrosis in Real Life.
Morena D; Fernández J; Campos C; Castillo M; López G; Benavent M; Izquierdo JL
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836204
[TBL] [Abstract][Full Text] [Related]
11. Use of Natural Language Processing of Patient-Initiated Electronic Health Record Messages to Identify Patients With COVID-19 Infection.
Mermin-Bunnell K; Zhu Y; Hornback A; Damhorst G; Walker T; Robichaux C; Mathew L; Jaquemet N; Peters K; Johnson TM; Wang MD; Anderson B
JAMA Netw Open; 2023 Jul; 6(7):e2322299. PubMed ID: 37418261
[TBL] [Abstract][Full Text] [Related]
12. Increased incidence of Graves' disease during the SARS-CoV2 pandemic.
Barajas Galindo DE; Ramos Bachiller B; González Roza L; García Ruiz de Morales JM; Sánchez Lasheras F; González Arnáiz E; Ariadel Cobo D; Ballesteros Pomar MD; Rodríguez IC
Clin Endocrinol (Oxf); 2023 May; 98(5):730-737. PubMed ID: 36510647
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Prognosis of COVID-19 in Patients with COPD.
Graziani D; Soriano JB; Del Rio-Bermudez C; Morena D; Díaz T; Castillo M; Alonso M; Ancochea J; Lumbreras S; Izquierdo JL
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33053774
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.
Türk SM; Öztürk Z; Karataş D; Erkorkmaz Ü; Gönüllü E
Turk J Med Sci; 2022 Apr; 52(2):522-523. PubMed ID: 36161620
[TBL] [Abstract][Full Text] [Related]
15. Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans.
Razjouyan J; Helmer DA; Lynch KE; Hanania NA; Klotman PE; Sharafkhaneh A; Amos CI
Nicotine Tob Res; 2022 Mar; 24(5):785-793. PubMed ID: 34693967
[TBL] [Abstract][Full Text] [Related]
16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
17. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
18. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
19. Controversy over smoking in COVID-19-A real world experience in New York city.
Ho KS; Narasimhan B; Sheehan J; Wu L; Fung JY
J Med Virol; 2021 Jul; 93(7):4537-4543. PubMed ID: 33325049
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional analysis of tobacco addiction in hospitalized COVID-19 patients.
Darılmaz Yüce G; Torun Ş; Hekimoğlu K; Tuna D; Sözbilici BR; Çetin HO; Narlıoğlu ME; Ballı M; Özyeşil AS; Yavuz Çolak M; Ulubay G; Akçay MŞ
Tuberk Toraks; 2022 Sep; 70(3):252-262. PubMed ID: 36164949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
